SCHEMBL2080407

SCHEMBL2080407

CC(C)(C)[C@@]1(CC#N)C[C@@H](O[Si](C)(C)C(C)(C)C)CN1C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPM1D O15297 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18394294 1.00 PPM1D (0.33) PPM1D
SCHEMBL140873 0.88 PPM1D (0.33) PPM1D
SCHEMBL2386709 0.85 PPM1D (0.35) PPM1D
SCHEMBL142690 0.85 PPM1D (0.35) PPM1D
SCHEMBL139881 0.85 PPM1D (0.35) PPM1D
SCHEMBL2387182 0.82 PPM1D (0.34) PPM1D
SCHEMBL28037304 0.82 PPM1D (0.34) PPM1D
SCHEMBL16538825 0.81 PPM1D (0.33) PPM1D
SCHEMBL2081002 0.79 PPM1D (0.32) PPM1D
SCHEMBL27224277 0.78 PPM1D (0.32) PPM1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906532-B2 Antiserotonine agents; gastrointestinal disorders; irritable bowel syndrome; central nervous system disorders; Alzheimer's disease; cognition activators; analgesics; cardiovascular disorders; antidiabetic agents; sleep disorders PFIZER INC. (US) 2011-03-15 US disclosed